Aleks Alacahan

Aleks Alacahan

Head of US Sales Biocon Biologics
Aleks Alacahan

Award-winning business leader with a track record of successfully revitalizing organizations and driving unprecedented sales excellence. Extensive experience in biologics, small molecules, devices and rare disease. As a transformational and inspirational executive, I’ve built a career leading sales and business development teams that deliver exceptional performance in the highly competitive biopharmaceutical medical device and clinical diagnostics space. Throughout my career, I’ve been selected to stabilize multibillion-dollar businesses, launch new products, lead startups, and drive organizational transformation, resulting in consistent growth trajectory. I’m also known for assembling, coaching and leading new/existing teams that achieve aggressive goals for new product launches. Highly analytical, I possess a unique ability to take an idea from concept to full execution through careful planning and consensus, resulting in long-term sustainability and market share growth.

Tuesday, April 21

11:05 AM CRO Learning Lab: Simplifying Deal Review Rhythm to Strengthen Late-Stage Execution

Deal reviews often become bloated, inconsistent, or overly tactical. Participants break down how to create a predictable review cadence that sharpens late-stage movement and eliminates preventable delays.

  • Focus deal reviews on risk, not repetition
  • Set clear expectations for what qualifies as ready-to-close
  • Improve manager consistency in identifying blockers

Check out the incredible speaker line-up to see who will be joining Aleks.

Download The Latest Agenda